PARIS (Reuters) - The French government needs guarantees from drugmaker Sanofi that production of its popular Doliprane ...

Sanofi confirmed on Monday plans to sell a controlling stake in its over-the-counter unit to a US investment fund, ...

Sanofi announced on Monday that it had entered into exclusive negotiations with US investment fund CD&R to sell it a majority ...

French drugmaker Sanofi's Monday confirmation that it plans to sell a controlling stake in its over-the-counter unit to a US ...

France will take a stake in Sanofi's Opella through the Public Investment Bank (BPI), finance minister Antoine Armand said on ...

Under the trilateral deal signed by Sanofi, CD&R and the government, Opella will have to pay a €40 million penalty if it ...

The sale of a French drugmaker to an American group is likely to now go ahead after French Economy Minister Antoine Armand ...

Politicians from across the political spectrum are up in arms over healthcare giant Sanofi's plans to sell France's ...

The American private equity firm has agreed to French government demands about protecting jobs and investment in France.View ...

French pharmaceutical company Sanofi confirmed on Monday its plans to sell a controlling stake in its consumer health unit ...

The European Commission has approved 128 million euros ($139 million) of Swedish state aid to help steelmaker SSAB ...

Sanofi and CD&R have entered exclusive negotiations for CD&R to acquire a 50% controlling stake in Opella, Sanofi’s consumer ...